$VERU
VERU INC. Stock $veru

$veru Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924025338 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q3
Revenue		$3.954M	$3.862M
YoY Change		18.34%	49.19%
Cost Of Revenue		$2.616M	$2.321M
YoY Change		23.94%	11.41%
Gross Profit		$1.338M	$1.541M
YoY Change		8.73%	204.94%
Gross Profit Margin		33.84%	39.91%
Selling, General & Admin		$7.508M	$6.775M
YoY Change		-31.14%	-62.96%
% of Gross Profit		561.1%	439.57%
Research & Development		$4.879M	$6.604M
YoY Change		66.79%	-75.44%
% of Gross Profit		364.65%	428.52%
Depreciation & Amortization		$65.00K	$69.87K
YoY Change		22.64%	11.9%
% of Gross Profit		4.86%	4.53%
Operating Expenses		$12.39M	$13.38M
YoY Change		-10.42%	-70.39%
Operating Profit		-$10.94M	-$11.84M
YoY Change		-325.1%	-73.5%
Interest Expense		-$44.34K	$436.8K
YoY Change		-106.83%	-86.77%
% of Operating Profit
Other Income/Expense, Net		$132.2K	$164.7K
YoY Change		-91.26%	-54.23%
Pretax Income		-$10.81M	-$10.24M
YoY Change		-269.6%	-75.04%
Income Tax		$162.4K	$557.5K
% Of Pretax Income
Net Earnings		-$10.97M	-$10.79M
YoY Change		-273.72%	-73.69%
Net Earnings / Revenue		-277.42%	-279.48%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share		-$0.07	-$0.12
COMMON SHARES
Basic Shares Outstanding	146.4M	146.4M	90.28M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$29.15M	$9.625M
YoY Change		79.8%	-88.0%
Cash & Equivalents	$24.92M	$29.15M	$9.625M
Short-Term Investments
Other Short-Term Assets		$2.741M	$2.677M
YoY Change		-60.27%	-78.43%
Inventory	$4.144M	$4.942M	$6.697M
Prepaid Expenses
Receivables	$3.960M	$1.642M	$4.507M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$35.22M	$38.48M	$23.51M
YoY Change	49.85%	-10.98%	-77.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.285M	$1.491M	$1.653M
YoY Change	-22.27%	-0.07%	39.38%
Goodwill	$6.900M	$6.900M	$6.900M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$0.00		$5.952K
YoY Change	-100.0%		-99.85%
Long-Term Investments		$228.8K
YoY Change
Other Assets	$1.130M	$1.320M	$1.512M
YoY Change	-25.29%	-14.71%	-3.15%
Total Long-Term Assets	$25.20M	$26.16M	$27.09M
YoY Change	-6.99%	-18.2%	-13.61%
TOTAL ASSETS
Total Short-Term Assets	$35.22M	$38.48M	$23.51M
Total Long-Term Assets	$25.20M	$26.16M	$27.09M
Total Assets	$60.42M	$64.63M	$50.60M
YoY Change	19.41%	-14.05%	-62.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.037M	$3.018M	$14.58M
YoY Change	-79.17%	-83.34%	-33.75%
Accrued Expenses		$6.282M	$4.632M
YoY Change		-26.09%	-74.15%
Deferred Revenue	$400.0K	$333.0K	$105.0K
YoY Change	280.95%
Short-Term Debt		$0.00	$100.0K
YoY Change
Long-Term Debt Due		$986.4K	$864.6K
YoY Change		-7.11%	-26.04%
Total Short-Term Liabilities	$11.87M	$10.62M	$20.28M
YoY Change	-41.48%	-61.64%	-51.06%
LONG-TERM LIABILITIES
Long-Term Debt		$8.577M	$8.870M
YoY Change		-7.54%	-8.14%
Other Long-Term Liabilities	$4.462M	$4.739M	$29.95K
YoY Change	14798.89%	11715.65%	61.21%
Total Long-Term Liabilities	$4.462M	$4.739M	$29.95K
YoY Change	14798.89%	11715.65%	61.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.87M	$10.62M	$20.28M
Total Long-Term Liabilities	$4.462M	$4.739M	$29.95K
Total Liabilities	$28.10M	$27.01M	$32.81M
YoY Change	-14.36%	-33.81%	-40.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$294.6M	-$286.0M	-$258.7M
YoY Change	13.88%	21.77%	56.22%
Common Stock	$1.486M	$1.486M	$939.7K
YoY Change	58.11%	62.51%	13.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$7.807M
YoY Change			0.0%
Treasury Stock Shares
Shareholders Equity	$32.32M	$37.62M	$17.78M
YoY Change
Total Liabilities & Shareholders Equity	$60.42M	$64.63M	$50.60M
YoY Change	19.41%	-14.05%	-62.83%

Cashflow Statement

Concept	2024 Q2	2023 Q3
OPERATING ACTIVITIES
Net Income	-$10.97M	-$10.79M
YoY Change	-273.72%	-73.69%
Depreciation, Depletion And Amortization	$65.00K	$69.87K
YoY Change	22.64%	11.9%
Cash From Operating Activities	-$5.646M	-$9.494M
YoY Change	-69.37%	-54.53%
INVESTING ACTIVITIES
Capital Expenditures	$54.63K	$215.7K
YoY Change	112.73%	-244.96%
Acquisitions
YoY Change
Other Investing Activities	$110.0K	$1.000M
YoY Change	-98.17%
Cash From Investing Activities	$55.37K	$784.3K
YoY Change	-99.07%	-627.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.280K	2.114M
YoY Change	-99.94%	216.82%
NET CHANGE
Cash From Operating Activities	-5.646M	-9.494M
Cash From Investing Activities	55.37K	784.3K
Cash From Financing Activities	3.280K	2.114M
Net Change In Cash	-5.587M	-6.595M
YoY Change	-23.31%	-67.61%
FREE CASH FLOW
Cash From Operating Activities	-$5.646M	-$9.494M
Capital Expenditures	$54.63K	$215.7K
Free Cash Flow	-$5.700M	-$9.710M
YoY Change	-69.12%	-53.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	308000000
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	308000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	148567624
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93966402
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146383920
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91782698
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2183704
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2183704
CY2023Q3	us-gaap	Goodwill Goodwill	6900000	usd
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-13602
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WI
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	39-1144397
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2916 N. Miami Avenue, Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33127
	dei	City Area Code CityAreaCode	305
	dei	Local Phone Number LocalPhoneNumber	509-6897
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	VERU
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	146383920
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29150879	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9625494	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1642063	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4506508	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4942246	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6697117	usd
CY2024Q2	veru	Prepaid Research And Development Costs Current PrepaidResearchAndDevelopmentCostsCurrent	1125699	usd
CY2023Q3	veru	Prepaid Research And Development Costs Current PrepaidResearchAndDevelopmentCostsCurrent	1006252	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1615254	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1097851	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	38476141	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	22933222	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1491129	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1652732	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3756812	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4332473	usd
CY2024Q2	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	228824	usd
CY2023Q3	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	0	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12479488	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12707419	usd
CY2024Q2	us-gaap	Goodwill Goodwill	6878932	usd
CY2023Q3	us-gaap	Goodwill Goodwill	6878932	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1320328	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1518313	usd
CY2024Q2	us-gaap	Assets Assets	64631654	usd
CY2023Q3	us-gaap	Assets Assets	50023091	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3018334	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12931172	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3385464	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	990609	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2191054	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1987738	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Current ResidualRoyaltyAgreementLiabilityCurrent	986388	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Current ResidualRoyaltyAgreementLiabilityCurrent	864623	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1038795	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1036590	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10620035	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	17810732	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Noncurrent ResidualRoyaltyAgreementLiabilityNoncurrent	8577067	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Noncurrent ResidualRoyaltyAgreementLiabilityNoncurrent	8870136	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3074721	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3634114	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4739375	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29948	usd
CY2024Q2	us-gaap	Liabilities Liabilities	27011198	usd
CY2023Q3	us-gaap	Liabilities Liabilities	30344930	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1485676	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	939664	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	330561916	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	283894830	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-581519	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-581519	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-286039012	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256768209	usd
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	7806605	usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	7806605	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	37620456	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	19678161	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64631654	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50023091	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3953870	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3341185	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10229897	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12434946	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2615855	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2110567	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7063131	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6410198	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1338015	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1230618	usd
	us-gaap	Gross Profit GrossProfit	3166766	usd
	us-gaap	Gross Profit GrossProfit	6024748	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4879024	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8787636	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9515865	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47259464	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7507609	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10902916	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23389380	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41283275	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3911714	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3900000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	12386633	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	19690552	usd
	us-gaap	Operating Expenses OperatingExpenses	32905245	usd
	us-gaap	Operating Expenses OperatingExpenses	96354453	usd
CY2024Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	110000	usd
CY2023Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	4723623	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	1028372	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	4723623	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10938618	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13736311	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-28710107	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-85606082	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	127336	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	648917	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	437603	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2219840	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	83000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1789000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	102000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2319000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-117620	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-689548	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	294122	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	131133	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	736440	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	409059	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	132166	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1271216	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-288711	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	508219	usd
CY2024Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-10806452	usd
CY2023Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-12465095	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-28998818	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-85097863	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	162422	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57551	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	271985	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-77286	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-10968874	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-12522646	usd
	us-gaap	Net Income Loss NetIncomeLoss	-29270803	usd
	us-gaap	Net Income Loss NetIncomeLoss	-85020577	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146383169
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88266152
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131010713
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83218748
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	19678161	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3406949	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	164313	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8275981	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	51602272	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3634171	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	851	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10025948	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	45209644	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3376406	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3280	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-10968874	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	37620456	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	82797317	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4845269	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	257132	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-38708957	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	49190761	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3837598	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	79478	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	78677	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-33788974	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21811737	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4550832	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	26172	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-12522646	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20646236	usd
	us-gaap	Net Income Loss NetIncomeLoss	-29270803	usd
	us-gaap	Net Income Loss NetIncomeLoss	-85020577	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	203033	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	199690	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3900000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3911714	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	575661	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	556475	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	69304	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1832092	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	1028372	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	4723623	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10417526	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	13233699	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	227931	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-213172	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	102000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2319000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-689548	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1266167	usd
	us-gaap	Inventory Write Down InventoryWriteDown	195587	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-2592	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	290	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2864445	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4729697	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-488704	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-845688	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	609130	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7030293	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5173463	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6059390	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2763598	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-6707614	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-557188	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-453809	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17316239	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-78521354	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	110000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95286	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	452826	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14714	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5547174	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3280	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	336610	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	263757	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1425174	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	132975	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	897422	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36826910	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8996641	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19525385	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63977539	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9625494	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80190675	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29150879	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16213136	usd
	us-gaap	Interest Paid Net InterestPaidNet	506907	usd
	us-gaap	Interest Paid Net InterestPaidNet	387748	usd
	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	918372	usd
	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	164313	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	104849	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	1008000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	264896	usd
CY2023Q2	veru	Prepaid Research And Development Costs Current PrepaidResearchAndDevelopmentCostsCurrent	3515463	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	32667682	usd
CY2023Q2	us-gaap	Assets Assets	60204082	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	15944004	usd
CY2023Q2	veru	Accrued Research And Development Liability AccruedResearchAndDevelopmentLiability	2037061	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26435863	usd
CY2023Q2	us-gaap	Liabilities Liabilities	39557846	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-248636094	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20646236	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60204082	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8787636	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	19690552	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13736311	usd
CY2023Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-12465095	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-12522646	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47259464	usd
	us-gaap	Operating Expenses OperatingExpenses	96354453	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-85606082	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-85097863	usd
	us-gaap	Net Income Loss NetIncomeLoss	-85020577	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
	us-gaap	Net Income Loss NetIncomeLoss	-85020577	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7030293	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6059390	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-6707614	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3953870	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3341185	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10229897	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12434946	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3953870	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3341185	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10229897	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12434946	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	333000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	105000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5581096	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	8445370	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3923857	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3923857	usd
CY2024Q2	veru	Accounts Receivable Allowance For Credit Loss Sales Returns And Discounts Current AccountsReceivableAllowanceForCreditLossSalesReturnsAndDiscountsCurrent	15176	usd
CY2023Q3	veru	Accounts Receivable Allowance For Credit Loss Sales Returns And Discounts Current AccountsReceivableAllowanceForCreditLossSalesReturnsAndDiscountsCurrent	15005	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1642063	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4506508	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3923857	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12143	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3911714	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3923857	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3923857	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	728881	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1854810	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	50484	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	112799	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5610384	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4913295	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	6389749	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	6880904	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1447503	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	183787	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4942246	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6697117	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5445010	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5440686	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3953881	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3787954	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1491129	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1652732	usd
CY2024Q2	us-gaap	Depreciation Depreciation	65000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	53000	usd
	us-gaap	Depreciation Depreciation	197000	usd
	us-gaap	Depreciation Depreciation	146000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	6900000	usd
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Gross ResidualRoyaltyAgreementLiabilityGross	346000	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Gross ResidualRoyaltyAgreementLiabilityGross	346000	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Accumulated Accretion ResidualRoyaltyAgreementLiabilityAccumulatedAccretion	12815552	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Accumulated Accretion ResidualRoyaltyAgreementLiabilityAccumulatedAccretion	12377949	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Increase Decrease From Addition Payment ResidualRoyaltyAgreementLiabilityIncreaseDecreaseFromAdditionPayment	-4827097	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Increase Decrease From Addition Payment ResidualRoyaltyAgreementLiabilityIncreaseDecreaseFromAdditionPayment	-4320190	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Net Excluding Embedded Derivative Liability ResidualRoyaltyAgreementLiabilityNetExcludingEmbeddedDerivativeLiability	8334455	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Net Excluding Embedded Derivative Liability ResidualRoyaltyAgreementLiabilityNetExcludingEmbeddedDerivativeLiability	8403759	usd
CY2024Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1229000	usd
CY2023Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1331000	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Total ResidualRoyaltyAgreementLiabilityTotal	9563455	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Total ResidualRoyaltyAgreementLiabilityTotal	9734759	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Current ResidualRoyaltyAgreementLiabilityCurrent	986388	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Current ResidualRoyaltyAgreementLiabilityCurrent	864623	usd
CY2024Q2	veru	Residual Royalty Agreement Liability Noncurrent ResidualRoyaltyAgreementLiabilityNoncurrent	8577067	usd
CY2023Q3	veru	Residual Royalty Agreement Liability Noncurrent ResidualRoyaltyAgreementLiabilityNoncurrent	8870136	usd
CY2023Q1	veru	Security Offering Maximum Value Of Securities Shelf Registration SecurityOfferingMaximumValueOfSecuritiesShelfRegistration	200000000	usd
CY2024Q2	veru	Security Offering Remaining Value Of Securities Shelf Registration SecurityOfferingRemainingValueOfSecuritiesShelfRegistration	35100000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3376406	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4550832	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10417526	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13233699	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0964	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0496	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0886	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0137	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0448	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0351	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0449	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0392	pure
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.37
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.12
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.22
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.55
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17367643
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.28
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2281500
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.45
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2734
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.2
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1050081
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.51
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18596328
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.63
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M13D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	76000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12838518
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M9D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q2	us-gaap	Share Price SharePrice	0.84
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	486000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3280	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	336610	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	270629	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	277211	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	808952	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	838112	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10691	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10903	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	31611	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	32003	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	14840	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	33926	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	58642	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	136569	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	-0	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	44844	usd
	us-gaap	Sublease Income SubleaseIncome	15148	usd
	us-gaap	Sublease Income SubleaseIncome	134533	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	296160	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	277196	usd
	us-gaap	Lease Cost LeaseCost	884057	usd
	us-gaap	Lease Cost LeaseCost	872151	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	797000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	777000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.077	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2269355	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2617670	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6089752	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-17870551	usd
CY2024Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-175713	usd
CY2023Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-202682	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-471521	usd
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1383691	usd
CY2024Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	30038	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-262005	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	291056	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	185564	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	309	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	0	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	309	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	63849	usd
CY2024Q2	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-1109784	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-2835378	usd
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-692784	usd
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-415378	usd
CY2024Q2	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	5041	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	406324	usd
	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-77905	usd
	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	307188	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	302155	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	-24691	usd
	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	302155	usd
	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	-24691	usd
CY2024Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1157182	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-55884	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5621937	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	18257505	usd
CY2024Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2981	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-21219	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2922	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-27837	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	162422	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57551	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	271985	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-77286	usd

Files In Submission

Name	View Source	Status
0001437749-24-025338-index-headers.html	Edgar Link	pending
0001437749-24-025338-index.html	Edgar Link	pending
0001437749-24-025338.txt	Edgar Link	pending
0001437749-24-025338-xbrl.zip	Edgar Link	pending
ex_674186.htm	Edgar Link	pending
ex_674187.htm	Edgar Link	pending
ex_674188.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
veru-20240630.xsd	Edgar Link	pending
veru20240630_10q.htm	Edgar Link	pending
veru-20240630_cal.xml	Edgar Link	unprocessable
veru-20240630_lab.xml	Edgar Link	unprocessable
veru-20240630_def.xml	Edgar Link	unprocessable
veru-20240630_pre.xml	Edgar Link	unprocessable
veru20240630_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VERU
VERU INC. Stock $veru

2024 Q3 Form 10-Q Financial Statement

#000143774924025338 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERU VERU INC. Stock $veru

2024 Q3 Form 10-Q Financial Statement

#000143774924025338 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERU
VERU INC. Stock $veru